X

pharmaceuticals

Alembic Pharmaceuticals Ltd Q2FY24; 3% rise in Profits

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The…

Zydus Lifesciences Ltd Q2FY24; 53% rise in Profits

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From…

Alkem Laboratories Ltd Q2FY24; 77% rise in Profits

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale…

Aarti Pharmalabs Ltd Q2FY24; 2% rise in Profits

Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals Financial Results: Aarti Pharmalabs Ltd reported Revenues…

Glenmark Pharmaceuticals Ltd Q2FY24; 6% rise in Revenue

Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in…

Tarsons Products Ltd Q2FY24; 38% fall in Profits

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables'…

Biocon Ltd Q2FY24; 111% rise in Profits

Biocon is engaged in the business of manufacture of biotechnology products and research services. Financial Results: Biocon Ltd reported Revenues…

Solara Active Pharma Sciences Ltd Q2FY24; 26% rise in Revenue

Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading…

Granules India Ltd Q2FY24; 30% fall in Profits

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical…

Glaxosmithkline Pharmaceuticals Ltd Q2FY24; 13% rise in Profits

GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people. Financial Results: Glaxosmithkline…